Skip to content
10-K

Annual Report

BARINTHUS BIOTHERAPEUTICS PLC BRNS

0001828185-26-000012

← back to feed
Filed
Mar 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 6, 2026 40.85M sh
Shares Diluted FY 2025 · Dec 31, 2025 40.53M sh
Shares Diluted FY 2025 · Dec 31, 2024 39.35M sh
Capex FY 2025 · Dec 31, 2025 $37K
Capex FY 2025 · Dec 31, 2024 $892K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$47.98M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$28.94M
Cash And Equivalents FY 2025 · Dec 31, 2025 $70.46M
Cash And Equivalents FY 2025 · Dec 31, 2024 $110.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $74.21M
Stockholders Equity FY 2025 · Dec 31, 2024 $130.03M
Current Liabilities FY 2025 · Dec 31, 2025 $10.02M
Current Liabilities FY 2025 · Dec 31, 2024 $15.66M
Total Liabilities FY 2025 · Dec 31, 2025 $23.88M
Total Liabilities FY 2025 · Dec 31, 2024 $30.19M
Current Assets FY 2025 · Dec 31, 2025 $77.79M
Current Assets FY 2025 · Dec 31, 2024 $125.74M
Total Assets FY 2025 · Dec 31, 2025 $98.17M
Total Assets FY 2025 · Dec 31, 2024 $160.33M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.64
Eps Diluted FY 2025 · Dec 31, 2024 −$1.55
Eps Basic FY 2025 · Dec 31, 2025 −$1.64
Eps Basic FY 2025 · Dec 31, 2024 −$1.55
Sga Expense FY 2025 · Dec 31, 2025 $40.83M
Sga Expense FY 2025 · Dec 31, 2024 $29.67M
Rd Expense FY 2025 · Dec 31, 2025 $25.56M
Rd Expense FY 2025 · Dec 31, 2024 $42.24M
Net Income FY 2025 · Dec 31, 2025 −$66.43M
Net Income FY 2025 · Dec 31, 2024 −$61.07M
Operating Income FY 2025 · Dec 31, 2025 −$70.56M
Operating Income FY 2025 · Dec 31, 2024 −$67.97M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $14.97M